Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.
Clinical role
Post-processing bone-age measurement/quantification with report generation; optional heatmap is explanatory only
Images and patients
X-ray/Radiography · Left hand and wrist; skeletal maturity/bone age
Key limitation
Keep in mind: Do not rely on results alone for diagnosis. Excluded are growth disorders caused by listed congenital anomalies or other complex skeletal conditions, and images with tumors, fracture sequelae, congenital deformities, or other notable anatomic variations in the required region. Heatmap is supplementary and not for growth-plate localization or independent bone-age assessment; confidence graph is not clinically validated or intended to select a specific bone age.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Left hand and wrist; skeletal maturity/bone age Input: DICOM-compliant 2D PA left-hand radiographs for patients aged 2-18 years, with the entire left hand and wrist visible and without major destruction, deformity, fracture, excessive motion, or other major artifacts.
Who uses it?Intended users: Pediatric radiologists
What does the software produce?Output: Quantitative bone-age assessment in years and a generated report. An optional heatmap illustrates regions contributing to the model output, and a confidence-score graph illustrates output-distribution sharpness; neither is a clinical diagnosis or independently calibrated clinical likelihood.
What is its most important limitation?Key limitation: Do not rely on results alone for diagnosis. Excluded are growth disorders caused by listed congenital anomalies or other complex skeletal conditions, and images with tumors, fracture sequelae, congenital deformities, or other notable anatomic variations in the required region. Heatmap is supplementary and not for growth-plate localization or independent bone-age assessment; confidence graph is not clinically validated or intended to select a specific bone age.
Clinical takeaway. Clinical role: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.
Evidence takeaway. Evidence from the reviewed source record: An independent FDA performance evaluation used 600 cases aged 2-18 from five US sites and multiple clinical organizations; four evaluators established the reference standard and none of the cases were used for training/development. Deming regression reported slope 1.000 (95% CI 0.989-1.002) and intercept 0.08 (-0.004-0.158). Bland-Altman limits of agreement were -0.66 to 0.71 years; mean difference was 0.026 years with SD 0.3505, and 89% of cases differed by less than 0.5 years. Heatmap testing used 30 cases; the packet reports SSIM criteria results and masking changes in 27 of 30 cases.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.
DICOM-compliant 2D PA left-hand radiographs for patients aged 2-18 years, with the entire left hand and wrist visible and without major destruction, deformity, fracture, excessive motion, or other major artifacts.
Quantitative bone-age assessment in years and a generated report. An optional heatmap illustrates regions contributing to the model output, and a confidence-score graph illustrates output-distribution sharpness; neither is a clinical diagnosis or independently calibrated clinical likelihood.
Do not rely on results alone for diagnosis. Excluded are growth disorders caused by listed congenital anomalies or other complex skeletal conditions, and images with tumors, fracture sequelae, congenital deformities, or other notable anatomic variations in the required region. Heatmap is supplementary and not for growth-plate localization or independent bone-age assessment; confidence graph is not clinically validated or intended to select a specific bone age.
An independent FDA performance evaluation used 600 cases aged 2-18 from five US sites and multiple clinical organizations; four evaluators established the reference standard and none of the cases were used for training/development. Deming regression reported slope 1.000 (95% CI 0.989-1.002) and intercept 0.08 (-0.004-0.158). Bland-Altman limits of agreement were -0.66 to 0.71 years; mean difference was 0.026 years with SD 0.3505, and 89% of cases differed by less than 0.5 years. Heatmap testing used 30 cases; the packet reports SSIM criteria results and masking changes in 27 of 30 cases.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
An independent FDA performance evaluation used 600 cases aged 2-18 from five US sites and multiple clinical organizations; four evaluators established the reference standard and none of the cases were used for training/development. Deming regression reported slope 1.000 (95% CI 0.989-1.002) and intercept 0.08 (-0.004-0.158). Bland-Altman limits of agreement were -0.66 to 0.71 years; mean difference was 0.026 years with SD 0.3505, and 89% of cases differed by less than 0.5 years. Heatmap testing used 30 cases; the packet reports SSIM criteria results and masking changes in 27 of 30 cases.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
MediAI-BA regulatory performance study summary
DesignStand-Alone Performance
PopulationPediatric
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K250914
Samplen=600
Sites5
IndependenceIndependence not established
K250914
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K250914. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM-compliant 2D PA left-hand radiographs for patients aged 2-18 years, with the entire left hand and wrist visible and without major destruction, deformity, fracture, excessive motion, or other major artifacts.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: DICOM-compliant image input in a healthcare facility or hospital, with report creation. The FDA packet does not establish a specific PACS, RIS, EHR, or deployment interface.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-08 ·
Returned objects
Source context, not route validation: Quantitative bone-age assessment in years and a generated report. An optional heatmap illustrates regions contributing to the model output, and a confidence-score graph illustrates output-distribution sharpness; neither is a clinical diagnosis or independently calibrated clinical likelihood.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Quantitative bone-age assessment in years and a generated report. An optional heatmap illustrates regions contributing to the model output, and a confidence-score graph illustrates output-distribution sharpness; neither is a clinical diagnosis or independently calibrated clinical likelihood.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
DICOM-compliant image input in a healthcare facility or hospital, with report creation. The FDA packet does not establish a specific PACS, RIS, EHR, or deployment interface.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
23Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K250914 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-09-08 - Exact FDA submission
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-08 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Analyzes two-dimensional bitewing and periapical radiographs of permanent teeth in patients aged 15 and older to identify and localize caries, calculus, periapical radiolucency, root canal filling deficiency, discrepancy at an existing restoration margin, and bone loss; also supports alveolar bone-level measurement and restoration/dental-anatomy segmentation as an adjunct to dentist review.
Authorized purpose: VEA Align is cloud-based software for orthopedic applications in adult and pediatric populations using two-dimensional X-ray images from EOS imaging systems to display interactive landmarks and assess patient-specific global alignment, with angle and length measurements for spinal deformities, degenerative diseases, and lower-limb alignment disorders or deformities. It is suitable for patients aged 7 years and older. spineEOS assists healthcare professionals with preoperative planning of spine surgery using EOS images, associated three-dimensional datasets, measurements, and patient-specific surgical-planning tools.
Modality
X-ray/Radiography
Anatomy
Spine and lower-limb alignment; frontal and lateral EOS images and associated 3D datasets
Authorized purpose: Post-processing segmentation, measurement, threshold labeling, and export of quantitative lumbar-spine measurements to support clinical review; not diagnosis.
Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.